Stock market anomaly | Medtech (02291.HK) surged over 14% in the final trading session. MemoSorb ASD/VSD occluder has obtained approval for listing in Saudi Arabia.

According to the Securities Times app, Xintai Medical (02291.HK) surged more than 14% in the final trading session, with a cumulative increase of over 35% for the month. As of the time of writing, it rose by 11.66% to 13.6 Hong Kong dollars, with a turnover of 40.94 million Hong Kong dollars.